CLINICAL_TRIALS
withdrawal
· 2013-04-19
Clinical Trial Update: Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors
Summary
A pediatric clinical trial investigating cerebrospinal fluid and angiogenesis proteins in newly diagnosed brain and central nervous system tumors has been withd…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pediatric Brain Tumor Consortium | Conditions: Brain and Central Nervous System Tumors | Status: WITHDRAWN